BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15139069)

  • 21. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
    Engellau J; Bendahl PO; Persson A; Domanski HA; Akerman M; Gustafson P; Alvegård TA; Nilbert M; Rydholm A
    Hum Pathol; 2005 Sep; 36(9):994-1002. PubMed ID: 16153463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological vascular invasion by tumors is a risk factor for distant metastasis in malignant fibrous histiocytoma.
    Yonemoto T; Tatezaki S; Ishii T; Iwata S; Takeuchi Y; Araki A
    Anticancer Res; 2005; 25(2B):1337-42. PubMed ID: 15865088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for first recurrence in patients with retroperitoneal sarcoma.
    Avancès C; Mottet N; Mahatmat A; Chapuis E; Serre I; Culine S
    Urol Oncol; 2006; 24(2):94-6. PubMed ID: 16520270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of residual tumor on local recurrence after unplanned resection of soft tissue sarcoma].
    Peiper M; Knoefel WT; Izbicki JR
    Dtsch Med Wochenschr; 2004 Jan; 129(5):183-7. PubMed ID: 14735414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
    ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
    Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy.
    Cahlon O; Spierer M; Brennan MF; Singer S; Alektiar KM
    Cancer; 2008 Jun; 112(12):2774-9. PubMed ID: 18429001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant fibrous histiocytoma of the extremity.
    Salo JC; Lewis JJ; Woodruff JM; Leung DH; Brennan MF
    Cancer; 1999 Apr; 85(8):1765-72. PubMed ID: 10223571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
    Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
    J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
    Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
    J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should tumor depth be included in prognostication of soft tissue sarcoma?
    Rydholm A; Gustafson P
    BMC Cancer; 2003 May; 3():17. PubMed ID: 12769830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Healey JH; Singer S
    J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.
    Eilber FC; Brennan MF; Riedel E; Alektiar KM; Antonescu CR; Singer S
    Ann Surg Oncol; 2005 Mar; 12(3):228-36. PubMed ID: 15827815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report.
    Shinjo K
    Jpn J Clin Oncol; 1994 Jun; 24(3):154-9. PubMed ID: 8007425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of surgery for malignant fibrous histiocytomas of soft tissue.
    Matsumoto S; Ahmed AR; Kawaguchi N; Manabe J; Matsushita Y
    Int J Clin Oncol; 2003 Apr; 8(2):104-9. PubMed ID: 12720103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
    Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
    Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome.
    Costa MJ; Weiss SW
    Am J Surg Pathol; 1990 Dec; 14(12):1126-32. PubMed ID: 2174650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Gleason BC; Fletcher CD
    Am J Surg Pathol; 2008 Mar; 32(3):354-62. PubMed ID: 18300816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.